Status:
COMPLETED
See and Treat in an Outpatient Setting in Women Above 45 Years With Cervical Dysplasia
Lead Sponsor:
University of Aarhus
Conditions:
Cervical Dysplasia
Cervical Lesion
Eligibility:
FEMALE
45+ years
Phase:
NA
Brief Summary
The study will investigate if implementation of "see and treat" in the outpatient clinic can optimize the diagnosis, clinical follow-up and treatment of older women with positive cervical screening te...
Detailed Description
In Denmark, 370 women are diagnosed with cervical cancer every year and approximately 100 women die from the disease. Young women can be protected with the HPV vaccine, but it will take decades before...
Eligibility Criteria
Inclusion
- Women ≥ 45 years with a positive screening test (abnormal cytology and/or persistence HPV positive) who are referred to the Department of Obstetrics and Gynecology.
- Type 2 or 3 transformation zone (a partly or invisible transformation zone).
Exclusion
- Type 1 transformation zone (fully visible)
- Current or previous diagnosis of cervical cancer.
- Pregnancy or pregnancy wish.
- Previously cone biopsy
Key Trial Info
Start Date :
March 13 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT04298957
Start Date
March 13 2019
End Date
January 31 2022
Last Update
May 18 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Horsens Regional Hospital
Horsens, Jutland, Denmark, 8700
2
Randers Regional Hospital
Randers, Jutland, Denmark, 8930
3
Viborg Regional Hospital
Viborg, Jutland, Denmark, 8800